Rock Springs has led a round that will drive R&D and recruitment at AI drug design company Genesis Therapeutics, which emerged out of Stanford.

George Washington and Minnesota universities-founded cell therapy developer Catamaran has raised cash to move two assets toward the clinic.

UC Berkeley-founded emissions measurement provider Aclima has raised cash in a round that included Splunk, RBVC and Microsoft Climate Innovation Fund.

The property developer has backed Chinese Academy of Medical Sciences spinout Juventas to help advance its clinical-stage oncology cell therapy candidates.

MPM Capital and Qiming Venture Partners USA have co-led a series A round for Umoja Biopharma, based on research at Purdue University and Seattle Children’s Research Institute.

UCL and Francis Crick-founded Achilles has secured $69.9m in its series C round.

EPFL’s chip-link technology provider has added more than $36m to a Swisscom-backed round that now totals $92.3m, taking its total funding to almost $133m.

Nereid Therapeutics will advance research by Clifford Brangwynne of Princeton University following its launch with a $50m series A round from Apple Tree Partners.

Syncona has launched Purespring to commercialise gene therapies aimed at kidney diseases that are based on work at University of Bristol.

MIT-founded grid battery spinout Form Energy expects to reveal the round's investors within weeks after it pushed its overall funding to more than $120m.